Healthcare >> CEO Interviews >> September 21, 2000

Christopher Samler – Weston Medical Group Plc (wmg.l)

CHRISTOPHER SAMLER was appointed as Chief Executive Officer of Weston Medical Group Plc in June 1997. During the three years prior to his appointment, Mr. Samler served as CEO of Imutran Ltd, a Cambridge (UK) biotechnology company developing leading-edge organ transplantation technology, and managed the sale and integration of the business with the Swiss pharmaceutical company Novartis. A former British Army officer who holds an MBA from Harvard University, Mr. Samler has extensive experience in the healthcare industry gained with Baxter International Inc. and Bentley Laboratories b.v., a European manufacturer of disposable surgical apparatus. As well as serving on the Board of Weston Medical, he is a Board member of Interactiva GmbH, the Germany bioinformatics company. Profile
TWST: Could you give us a brief overview of Weston Medical Group including the companys history, products and services?



Mr. Samler: Weston-Medical is a leading drug delivery development